Chondrosarcoma Specialist Surgeon Singapore

Surgical Management of Cartilaginous Malignancy and Reconstruction 

We manage chondrosarcoma as a relentless challenge of surgical margins and structural restoration. Under the clinical direction of Dr. Saminathan Suresh Nathan, our approach centers on the reality that these tumors are predominantly chemo-resistant, necessitating radical, wide oncological resections. By utilizing thirty years of surgical discernment—integrating 3D-planned resections, megaprostheses, and custom biological grafts—we focus on achieving clearance while preserving the functional endurance of the human frame. Chondrosarcoma are a common malignant solid tumor of bone especially in Grade I forms. The grade II and II tumors are rare. They typically happen in the fourth and fifth decades of life. Treatment involves the use of surgery with or without cryotherapy. Radiation and chemotherapy is not usually necessary.

Surgical Considerations

• Oncological Margin Verification: Precise execution of wide resections to manage radio-resistant and chemo-resistant cartilaginous matrices.

• Anatomical Reconstruction: Utilization of custom-engineered pelvic and long-bone implants to restore weight-bearing mechanics after radical excision.

• Joint Preservation: Assessment of joint-sparing resections when tumors are localized to the metaphysis, ensuring long-term articular integrity.

The Athens Protocol: Surgical Precision in Chondrosarcoma

International Standard established at the 20th ISOLS General Meeting

Management of Chondrosarcoma is defined by a single variable: The First Margin. Because this tumor does not respond to conventional chemotherapy, the surgical execution is the only opportunity for a definitive cure.Our clinical approach is anchored in the global standards set by the International Society of Limb Salvage (ISOLS). Dr. Suresh Nathan’s expertise in this field is verified by his role on the Scientific Program Committee for the 20th ISOLS General Meeting in Athens, where he helped define the technical agenda for the world's leading oncology surgeons.

The "Joint Salvage Ethos" in Practice

In Chondrosarcoma, the greatest risk is a binary surgical approach. Most centers treat these tumors with either "under-surgery" (leading to recurrence) or "over-surgery" (unnecessary amputation). We utilize the Athens Protocol to navigate the "Biological Grey Zone":

• Differentiating the Grade: We use millimetric MRI-histological correlation to distinguish between Atypical Cartilaginous Tumors (ACT) and Grade 2 Chondrosarcomas. This dictates whether a joint can be saved through Intralesional Salvage or if a total reconstruction is required.

• Navigated Margin Control: For complex pelvic and sacral tumors, we apply the 3D-navigation standards discussed at the highest faculty levels. This ensures oncological clearance while preserving the critical nerves and bone structure necessary for mobility.

• The Zero-Recurrence Standard: A local recurrence in Chondrosarcoma is a biological catastrophe. By applying the "First Margin" philosophy, we ensure that the initial surgery is planned and executed to be the last surgery.

Figure 1. Five-year survival rates of chondrosarcoma are generally good at about 80%. This tumor exists in three grades with the poorer grades being responsible for the 30% fatalities seen above. Furthermore, the lower grade tumors can degrade "de-differentiate" into higher grades and it is important to remove them early and totally because of this.

Figure 2. Some of the worse challenges come with the higher grade of chondrosarcoma mainly because they do not respond to chemotherapy or radiation. Therefore the only recourse is to surgery. Occasionally, limb salvage is possible even in the very large tumors but the risk is very high. This patient had a neglected chondrosarcoma of the pelvis which was resected and reconstructed with a cadaveric bone transplant.